Loading clinical trials...

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT01281592

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

This is an open-label, phase 1 study to determine the maximum tolerated dose (MTD) or appropriate target dose if MTD not reached to identify the recommended phase 2 dose of LOR-253 HCl in patients wit...

Lead sponsor: Aptose Biosciences Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1/2

A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

NCT03548467 · Locally Advanced or Metastatic Solid Tumours

UNKNOWNPhase 1

A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours

NCT03658070 · Advanced or Metastatic Solid Tumours

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 25, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment36

Start dateJan 2011

Last updatedFeb 25, 2014

Condition

Advanced or Metastatic Solid Tumours

Locations shown

Memorial Sloan-Kettering Cancer Center

New York, New York

MD Anderson Cancer Center

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 25, 2014Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions